Types and severity of cutaneous toxicities to BRAF inhibitors are drug-specific and discrete: a single-center cohort study (Supplemental Material)

Name: Types and severity of cutaneous toxicities to BRAF inhibitors are drug-specific and discrete: a single-center cohort study (Supplemental Material)
Creator: Priya Sarlashkar
Published: 2024-06-28T19:30:35.572Z
Keywords: Dermatology, Dabrafenib, Encorafenib, Vemurafenib, Drug Hypersensitivity

Sarlashkar, Priya; Gill, Jennifer; Heberton, Meghan

doi:10.17632/yc9ks44gph.1

Types and severity of cutaneous toxicities to BRAF inhibitors are drug-specific and discrete: a single-center cohort study (Supplemental Material)

Published: 28 June 2024| Version 1 | DOI: 10.17632/yc9ks44gph.1

Contributors:

Priya Sarlashkar, Jennifer Gill, Meghan Heberton

Description

JAAD Supplemental Material

Files

Institutions

University of Texas Southwestern Medical Center at Dallas

Types and severity of cutaneous toxicities to BRAF inhibitors are drug-specific and discrete: a single-center cohort study (Supplemental Material)

Description

Files

Institutions

Categories

Licence